Creative Medical Technology Holdings, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Creative Medical Technology Holdings, Inc. (CELZ) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$100.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-14
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$100.00K.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$10.00K.
- Creative Medical Technology Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$10.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 0 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$100.00K 10-Q · filed 2017-08-14 | -$100.00K derived: sum of 3 quarters · filed 2017-08-14 | -$110.00K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-05-10 | -$10.00K derived: sum of 3 quarters · filed 2017-05-10 | -$10.00K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$10.00K derived: sum of 2 quarters · filed 2017-02-13 | -$10.00K derived: sum of 3 quarters · filed 2017-08-14 | -$10.00K 10-K · filed 2017-02-13 | |
| 2016-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$10.00K derived: sum of 2 quarters · filed 2017-08-14 | -$10.00K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |